Navigation Links
Reportlinker Adds Gastroesophageal Reflux Disease Therapy Area Pipeline Report
Date:9/7/2010

NEW YORK, Sept. 7 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Gastroesophageal Reflux Disease Therapy Area Pipeline Report

http://www.reportlinker.com/p0192863/Gastroesophageal-Reflux-Disease-Therapy-Area-Pipeline-Report.html

Life Science Analytics' Gastroesophageal Reflux Disease Therapy Area Pipeline Report contains detailed information on the gastroesophageal reflux disease drug pipeline. This report provides insight into the pipeline status of gastroesophageal reflux disease drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
  • Keep track of your competitors and partners by better understanding their product pipeline.
  • Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
  • Maintain a critical competitive advantage.

  • Epidemiology Report

    % of Products by Phase of Development

    No. of Products by Phase of Development

    Marketed Products vs. Pipeline Products

    Company Overview - Pipeline Projects

    Legend

    --Top 5 Companies in Early Stage Gastroesophageal Reflux Disease Products

    --Top 5 Companies in Late Stage Gastroesophageal Reflux Disease Products

    --Top 5 Companies in Marketed Gastroesophageal Reflux Disease Products

    Patent Expirations

    Upcoming Milestones

    Product Sales

    Full Pipeline View

    --Product Details : Unknown/Research

    --Product Details : Pre Clinical

    --Product Details : Phase I

    --Product Details : Phase II

    --Product Details : Phase III

    --Product Details : Pending Approval

    --Product Details : Approved

    --Product Details : On the Market

    News Updates

    --Intellectual Property

    --Product Updates

    --Regulatory

    To order this report:Therapy Industry: Gastroesophageal Reflux Disease Therapy Area Pipeline Report

    Therapy Business News

    More Market Research Report

    Check our Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
    '/>"/>

    SOURCE Reportlinker
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Reportlinker Adds US Disposable Medical Supplies Market Report
    2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
    3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
    4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
    5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
    6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
    7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
    8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
    9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
    10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
    11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
    (Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
    (Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
    Breaking Medicine Technology:
    (Date:2/24/2017)... ... February 24, 2017 , ... Rosica ... in thought leadership , media relations, social media, content marketing and SEO, ... be powered through Act-On, an intuitive marketing automation platform. , Rosica will now ...
    (Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
    (Date:2/23/2017)... , ... February 23, 2017 , ... The American Cleft ... ACPA’s 74th Annual Meeting. KLS is a longtime supporter of the event. , ... exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has ...
    (Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
    (Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
    Breaking Medicine News(10 mins):